SERPINA1 and pulmonary emphysema: Systemic levels of AAT in PI*MZ individuals do not generally fall below 11 μM, a value historically used as a theoretical ‘protective threshold’ for AAT therapy provision; levels below this threshold are thought to be associated with a higher risk of developing emphysema [7].